RE-RELEASE from Season 2: Mayo Clinic Talks "Evaluating Hematuria"
Dec 24, 2024
auto_awesome
Urologist Aaron M. Potretzke from Mayo Clinic dives into the nuances of hematuria, shedding light on both microscopic and gross forms of this common issue. He discusses when to investigate, emphasizing that malignancy is a serious concern but not the only cause. The conversation explores risk assessment for urinary tract cancers, particularly in high-risk groups like those with Lynch syndrome. Potretzke also outlines evaluation protocols for different patient risk levels, enhancing the understanding of shared decision-making in managing this condition.
Microscopic hematuria, while common, warrants careful evaluation to rule out serious conditions like urinary tract malignancy while many cases are benign.
Assessing a patient's risk for urinary malignancy requires considering factors such as age, sex, and smoking history to guide appropriate investigations.
Deep dives
Understanding Microscopic and Gross Hematuria
Microscopic hematuria is defined by the presence of three or more red blood cells per high power field in a urine specimen. This condition prompts evaluations to differentiate it from dipstick hematuria, where hemoglobin can give false positives. Often, gross hematuria is more alarming as it is associated with a higher rate of urinary malignancy, being found in about 13% of cases compared to only 3% for microscopic hematuria. However, while it is essential to investigate the causes of both types of hematuria, many instances are linked to benign conditions rather than malignancies.
Evaluating Risk Factors for Urological Malignancies
Assessing a patient's risk for urinary tract malignancies involves considering several factors, including age, sex, smoking history, and family history of cancer. High-risk patients typically include those over 60, long-term smokers, or those with significant red blood cell counts in urine. New guidelines have been introduced to help categorize these risks, enabling healthcare providers to determine the appropriate level of investigation and follow-up for patients presenting with hematuria. This risk stratification is vital, as it allows for tailored approaches based on each patient's unique context.
Management Strategies for Persistent Microscopic Hematuria
For patients exhibiting persistent microscopic hematuria with no obvious etiology, further evaluation is warranted, including cystoscopy and possibly imaging studies. Low-risk patients may opt for a repeat urinalysis before pursuing invasive testing, while high-risk patients require comprehensive investigations due to the potential for malignancy. Importantly, ongoing cases of hematuria that remain unexplained after initial screenings still necessitate close monitoring and potentially further imaging evaluations to rule out underlying issues. The evolution of management strategies reflects an emphasis on evidence-based practices, ensuring patients receive appropriate care without unnecessary procedures.
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode